3SBio Inc. (TRSBF)
PNK: TRSBF
· Real-Time Price · USD
0.83
0.00 (0.25%)
At close: Apr 30, 2025, 8:00 PM
0.25% (1D)
| Bid | 0.83 |
| Market Cap | 1.93B |
| Revenue (ttm) | 8.42B |
| Net Income (ttm) | 1.66B |
| EPS (ttm) | 0.09 |
| PE Ratio (ttm) | 9.2 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.83 |
| Volume | 313 |
| Avg. Volume (20D) | 4,346.868 |
| Open | 0.83 |
| Previous Close | 0.83 |
| Day's Range | 0.83 - 0.83 |
| 52-Week Range | 0.72 - 0.83 |
| Beta | 0.65 |
About TRSBF
3SBio Inc., an investment holding company, researches, develops, manufactures, markets, and sells biopharmaceutical products in the People's Republic of China. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; YISAIPU, a tumor necrosis factor for rheumatoid arthritis, ankylosing spondylitis, and psoriasis; EPIAO and SEPO recombinant human erythropoietins to treat...
Industry Biotechnology
Sector Healthcare
IPO Date Jun 26, 2018
Employees 5,577
Stock Exchange PNK
Ticker Symbol TRSBF
Website https://www.3sbio.com